These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2852965)

  • 41. Expression of dihydropyridine binding sites in renal epithelial cells.
    O'Neil RG; Reid JM; Williams RL; Karin NJ
    Biochem Biophys Res Commun; 1997 Aug; 237(1):41-5. PubMed ID: 9266826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A receptor of dihydropyridine blockaders of Ca2+ influx in human embryonic fibroblasts].
    Dudkin SM; Gnedoĭ SN; Cherniuk NN; Soldatov NM
    Tsitologiia; 1989 Mar; 31(3):312-8. PubMed ID: 2546305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heterogeneity of L-type calcium channel alpha 1 subunits: stereoselective discrimination of different populations by the novel 1,4-dihydropyridine B 874-67.
    Lakitsch M; Knaus HG; Topar G; Romanin C; Boer R; Flockerzi D; Striessnig J; Schindler H; Hoeltje HD; Glossmann H
    Mol Pharmacol; 1993 Feb; 43(2):293-301. PubMed ID: 8381514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allosteric interactions required for high-affinity binding of dihydropyridine antagonists to Ca(V)1.1 Channels are modulated by calcium in the pore.
    Peterson BZ; Catterall WA
    Mol Pharmacol; 2006 Aug; 70(2):667-75. PubMed ID: 16675661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary structure of the gamma subunit of the DHP-sensitive calcium channel from skeletal muscle.
    Jay SD; Ellis SB; McCue AF; Williams ME; Vedvick TS; Harpold MM; Campbell KP
    Science; 1990 Apr; 248(4954):490-2. PubMed ID: 2158672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fluorescent probing with felodipine of the dihydropyridine receptor and its interaction with the ryanodine receptor calcium release channel.
    Minarovic I; Mészáros LG
    Biochem Biophys Res Commun; 1998 Mar; 244(2):519-24. PubMed ID: 9514900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 1,4-Dihydropyridine receptor associated with Ca2+ channels in human embryonic fibroblasts.
    Dudkin SM; Gnedoj SN; Chernyuk NN; Soldatov NM
    FEBS Lett; 1988 Jun; 233(2):352-4. PubMed ID: 2454846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phosphorylation of the 1,4-dihydropyridine receptor of the voltage-dependent Ca2+ channel by an intrinsic protein kinase in isolated triads from rabbit skeletal muscle.
    Imagawa T; Leung AT; Campbell KP
    J Biol Chem; 1987 Jun; 262(17):8333-9. PubMed ID: 2439499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunochemical analysis of subunit structures of 1,4-dihydropyridine receptors associated with voltage-dependent Ca2+ channels in skeletal, cardiac, and smooth muscles.
    Schmid A; Barhanin J; Coppola T; Borsotto M; Lazdunski M
    Biochemistry; 1986 Jun; 25(12):3492-5. PubMed ID: 2424495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subunit composition of the purified dihydropyridine binding protein from skeletal muscle.
    Hamilton SL; Hawkes MJ; Brush K; Cook R; Chang RJ; Smilowitz HM
    Biochemistry; 1989 Sep; 28(19):7820-8. PubMed ID: 2558713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Denervation induced changes in level of Ca-antagonists binding cytosolic protein from white skeletal muscle.
    Lehotský J; Krizanová O; Bezáková G; Mézesová V
    Gen Physiol Biophys; 1991 Feb; 10(1):101-4. PubMed ID: 1831173
    [No Abstract]   [Full Text] [Related]  

  • 52. Identification of the site of interaction of the dihydropyridine channel blockers nitrendipine and azidopine with the calcium-channel alpha 1 subunit.
    Regulla S; Schneider T; Nastainczyk W; Meyer HE; Hofmann F
    EMBO J; 1991 Jan; 10(1):45-9. PubMed ID: 1846597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular modelling of the interaction of dihydropyridine drugs with their receptors.
    Höltje HD
    Prog Clin Biol Res; 1989; 291():237-41. PubMed ID: 2542977
    [No Abstract]   [Full Text] [Related]  

  • 54. The purified Ca2+ antagonist receptor from skeletal muscle: subunit structure, photoaffinity labeling and endogenous protein kinase activity.
    Tuana BS; Murphy BJ; Yi Q
    Mol Cell Biochem; 1988; 80(1-2):133-43. PubMed ID: 2845255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Binding of dihydropyridine calcium antagonists to membranes from human skeletal muscle.
    Krizanová O; Orlický J; Zachar J
    Gen Physiol Biophys; 1988 Jun; 7(3):324-7. PubMed ID: 2456251
    [No Abstract]   [Full Text] [Related]  

  • 56. Identification of an alpha subunit of dihydropyridine-sensitive brain calcium channels.
    Takahashi M; Catterall WA
    Science; 1987 Apr; 236(4797):88-91. PubMed ID: 2436296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isoform-specific inhibition of L-type calcium channels by dihydropyridines is independent of isoform-specific gating properties.
    Hu H; Marban E
    Mol Pharmacol; 1998 May; 53(5):902-7. PubMed ID: 9584217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The 1,4-dihydropyridine receptor: a regulatory component of the Ca2+ channel.
    Triggle DJ; Janis RA
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S949-55. PubMed ID: 6085383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A sensitive and rapid method for identification and characterization of low abundance receptors.
    Sunahara RK; Murphy BJ; Tuana BS
    Anal Biochem; 1990 Feb; 185(1):143-6. PubMed ID: 2160777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subunit composition of skeletal muscle transverse tubule calcium channels evaluated with the 1,4-dihydropyridine photoaffinity probe, [3H]azidopine.
    Ferry DR; Kämpf K; Goll A; Glossmann H
    EMBO J; 1985 Aug; 4(8):1933-40. PubMed ID: 2415355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.